Although previous reports highlighted that YY1 inhibition resulted in the increased sensitization of NHL cells to drug- or immune- induced cell death, all downstream pathways modulated by YY1 have not been comprehensively characterized yet [13,14]. This evidence concerns the gene YY1 and non-Hodgkin lymphoma.